Ingevity - NGVT Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NGVT shares.
View NGVT analyst ratings or view top-rated stocks.

3 brokers have issued 12-month price targets for Ingevity's shares. Their NGVT share price forecasts range from $85.00 to $100.00. On average, they anticipate the company's share price to reach $90.67 in the next twelve months. This suggests a possible upside of 28.9% from the stock's current price.
View analysts price targets for NGVT or view top-rated stocks among Wall Street analysts.

Ingevity's stock was trading at $70.44 at the start of the year. Since then, NGVT stock has decreased by 0.1% and is now trading at $70.36.
View the best growth stocks for 2023 here.

Ingevity saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 936,500 shares, an increase of 20.2% from the January 31st total of 778,800 shares. Based on an average daily trading volume, of 178,700 shares, the days-to-cover ratio is currently 5.2 days. Currently, 2.5% of the shares of the company are sold short.
View Ingevity's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our NGVT earnings forecast.

Ingevity Co. (NYSE:NGVT) released its quarterly earnings data on Monday, February, 27th. The company reported $0.57 earnings per share for the quarter, missing analysts' consensus estimates of $0.90 by $0.33. The firm earned $383.60 million during the quarter, compared to analysts' expectations of $395.77 million. Ingevity had a trailing twelve-month return on equity of 34.63% and a net margin of 12.68%. The firm's revenue for the quarter was up 14.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.78 EPS.

ETFs with the largest weight of Ingevity (NYSE:NGVT) stock in their portfolio include ProShares Smart Materials ETF (TINT), Putnam BioRevolution ETF (SYNB), Thrivent Small-Mid Cap ESG ETF (TSME), Putnam Sustainable Future ETF (PFUT), Invesco DWA Basic Materials Momentum ETF (PYZ), Pacer US Export Leaders ETF (PEXL), iShares U.S. Infrastructure ETF (IFRA) and Distillate Small/Mid Cash Flow ETF (DSMC).

Ingevity issued an update on its FY 2023 earnings guidance on Monday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.90 billion-$2.10 billion, compared to the consensus revenue estimate of $1.83 billion.

2 employees have rated Ingevity Chief Executive Officer John Fortson on Glassdoor.com. John Fortson has an approval rating of 100% among the company's employees. This puts John Fortson in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Verizon Communications (VZ), WestRock (WRK), Abbott Laboratories (ABT), Boeing (BA), Costco Wholesale (COST), Dominion Energy (D) and Johnson & Johnson (JNJ).

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

Ingevity's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include LSV Asset Management (4.05%), Thrivent Financial for Lutherans (2.76%), Dimensional Fund Advisors LP (1.95%), Maple Rock Capital Partners Inc. (1.85%), Brown Advisory Inc. (1.82%) and Geode Capital Management LLC (1.74%). Insiders that own company stock include Erik Spencer Ripple, Phillip John Platt, Richard Allen White Jr and Stuart Edward Jr Woodcock.
View institutional ownership trends.

Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NGVT stock can currently be purchased for approximately $70.36.

Ingevity (NYSE:NGVT) has a market capitalization of $2.62 billion and generates $1.67 billion in revenue each year. The company earns $211.60 million in net income (profit) each year or $5.48 on an earnings per share basis.

The company employs 2,050 workers across the globe.

Ingevity's mailing address is 4920 O`Hear Avenue Suite 400, North Charleston SC, 29406. The official website for the company is www.ingevity.com. The company can be reached via phone at (843) 740-2300, via email at daniel.gallagher@ingevity.com, or via fax at 843-740-8165.